BiotechTube
DIAsource ImmunoAssays

DIAsource ImmunoAssays

Louvain-la-Neuve, Belgium· Est.
diasource-diagnostics.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

DiaSource Diagnostics is a long-established, specialized player in the global IVD market, leveraging deep expertise in immunoassay technologies like RIA and ELISA. The company has expanded its portfolio from traditional manual kits to include innovative automated platforms, most notably its DIASPOT technology and Neptune instrument for autoimmune disease testing. Its recent integration into the BioVendor Group provides a stronger commercial and structural foundation for global growth. DiaSource operates as a revenue-generating, private entity, serving clinical laboratories worldwide with a focus on reliable, specialized diagnostic solutions.

EndocrinologyAutoimmunityInfectious DiseasesOncologyBone Metabolism

Technology Platform

Immunoassay development with expertise in RIA and ELISA. Proprietary DIASPOT platform for autoimmune testing, featuring immunodot (DOT) membrane technology, microarray (Multiquant) formats, and full automation via the Neptune instrument.

Opportunities

The growing global incidence of autoimmune diseases and the laboratory industry's shift toward automation create a significant opportunity for DiaSource's DIASPOT Neptune platform.
Integration into the BioVendor Group provides an expanded commercial network to access new geographic markets, particularly in Asia and the Middle East.

Risk Factors

Intense competition from larger IVD corporations with greater resources and broader portfolios poses a market challenge.
The company faces regulatory hurdles associated with IVD approvals (e.g., EU IVDR) and must successfully execute its integration into the BioVendor Group to realize anticipated strategic benefits.

Competitive Landscape

DiaSource competes in a crowded IVD market dominated by multinational corporations like Roche, Abbott, and Siemens Healthineers, as well as other specialty immunoassay companies. Its competitive edge lies in its deep expertise in niche areas like autoimmune diagnostics and its focused automation solution, but it must continually innovate to maintain relevance against larger players with integrated laboratory systems.

More companies in Diagnostics & Precision Medicine →More companies in Belgium →